医院手术量预测Ⅲ期食管癌指南一致性诊疗
该研究基于美国国家癌症数据库2004至2016年1345家医院数据,针对Ⅲ期食管癌制定四项指南质量指标,分析医院手术量、认证状态等因素与充分依从(≥85%患者依从)的关联。结果显示,充分依从率在淋巴结分期最低(12.6%),在新辅助治疗使用最高(84.8%);学术机构在诱导治疗、手术时机和切除完整性上依从率最高,但淋巴结分期最低。医院年食管切除术量每增加一例,诱导治疗和切除完整性的充分依从几率增加,而淋巴结分期的充分依从几率降低。
要点
- 医院年手术量增加与诱导治疗和切除完整性充分依从几率升高相关。
- 学术机构在诱导治疗、手术时机和切除完整性上依从率最高,但淋巴结分期最低。
- 淋巴结分期充分依从率仅12.6%,是四項指标中最薄弱的环节。
核心结论
- 高手术量和学术机构在部分领域更可能提供指南一致性诊疗,但并非所有领域均如此。
- 理解支持指南一致性诊疗的流程可能为改进提供有价值的机会。
研究设计与样本
- 基于美国国家癌症数据库2004至2016年1345家参与医院的数据进行分析。
- 从已发表指南制定Ⅲ期食管癌质量指标:新辅助治疗使用、至少15枚淋巴结手术采样、化疗或放疗后60天内切除、切除完整性。
- 使用逻辑回归模型分析医院手术量、项目认证、安全网状态、地理区域和患者出行距离与充分依从(≥85%患者依从)的关联。
主要发现
- 充分依从率在淋巴结分期最低(12.6%),在新辅助治疗使用最高(84.8%)。
- 学术机构在诱导治疗(77.2%;P < .001)、手术时机(56.6%;P < .001)和切除完整性(78.5%;P < .001)上充分依从率最高,但淋巴结分期最低(4.4%;P = .018)。
- 医院年食管切除术量每增加一例,诱导治疗(OR 1.16;95% CI 1.06-1.27)和切除完整性(OR 1.15;95% CI 1.06-1.25)的充分依从几率增加,而淋巴结分期(OR 0.76;95% CI 0.65-0.89)的充分依从几率降低。
关键数值与推荐
- 质量指标包括:新辅助治疗使用、至少15枚淋巴结手术采样、化疗或放疗后60天内切除、切除完整性。
- 充分依从定义为≥85%的患者依从。
临床怎么用
- 在心胸外科临床中,应关注Ⅲ期食管癌诊疗的指南一致性,尤其是淋巴结分期环节。
- 高手术量医院和学术机构在部分质量指标上表现更好,但需注意淋巴结分期依从性可能较低。
- 改进支持指南一致性诊疗的流程可能提升整体医疗质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Esophageal cancer is a deadly disease requiring multidisciplinary coordination of care and surgical proficiency for adequate treatment. We hypothesize that quality of care is varied nationally. METHODS: From published guidelines, we developed quality measures for management of stage III esophageal cancer: utilization of neoadjuvant therapy, surgical sampling of at least 15 lymph nodes, resection within 60 days of chemotherapy or radiation, and completeness of resection. Measure adherence was examined across 1345 hospitals participating in the National Cancer Database from 2004 to 2016. We examined the association of volume, program accreditation, safety net status, geographic region, and patient travel distance on adequate adherence (≥85% of patients are adherent) using logistic regression modeling. RESULTS: The rate of adequate adherence was worst in nodal staging (12.6%) and highest for utilization of neoadjuvant therapy (84.8%). Academic programs had the highest rate of adequate adherence for induction therapy (77.2%; P < .001), timing of surgery (56.6%; P < .001), and completeness of resection (78.5%; P < .001) but the lowest for nodal staging (4.4%; P = .018). For every additional esophagectomy performed per year, the odds of adequate adherence increased for induction therapy (odds ratio [OR]. 1.16; 95% confidence interval [CI], 1.06-1.27) and completeness of resection (OR, 1.15; 95% CI, 1.06-1.25) but decreased for nodal staging (OR, 0.76; 95% CI, 0.65-0.89). CONCLUSIONS: Care provided at higher volume and academic facilities was more likely to be guideline concordant in some areas but not in others. Understanding the processes that support the delivery of guideline concordant care may provide valuable opportunities for improvement.
引用
- Adhia AH, Feinglass JM, Schlick CJR, et al. Hospital Volume Predicts Guideline-Concordant Care in Stage III Esophageal Cancer. Ann Thorac Surg. 2021. PMID: 34481801. doi:10.1016/j.athoracsur.2021.07.092
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。